American Board of Optometry wins recent lawsuit

Article

Although the American Board of Optometry (ABO) was declared the winner in the recent American Optometric Society's (AOS) lawsuit against the organization, AOS President Pam Miller, OD, FAAO, JD, doesn't consider it a loss.

Key Points

Although the American Board of Optometry (ABO) was declared the winner in the recent American Optometric Society's (AOS) lawsuit against the organization, AOS President Pam Miller, OD, FAAO, JD, doesn't consider it a loss.

Instead, she said the AOS won significantly by keeping an injunction from 2011 in place-the ABO cannot claim that board-certified optometrists are any more qualified or competent than their colleagues who are licensed but have not sought certification.

Failing to prove that board certification offered a competitive advantage, could potentially cause economic damage and represented value to consumers beyond a medical license, AOS did not receive an injunction prohibiting the ABO from calling its program "board certification."

"To be considered an optometrist, you need to maintain a state license, and by being acknowledged by the American Board of Certification in Medical Optometry (ABCMO) is in effect already being certified," Dr. Miller said.

On the other side, the ABO said the AOS alleged that using "board-certified" was confusing to the public, an issue with which the Court disagreed.

"Board certification can demonstrate that optometrists are enrolled in a lifetime commitment to maintaining competence," Dr. Cockrell said. "The program is voluntary and serves as a measuring stick: 'Am I current?'"

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.